+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Insulin Delivery Devices Market - Global Forecast 2026-2032- Product Image
Insulin Delivery Devices Market - Global Forecast 2026-2032- Product Image
Sale

Insulin Delivery Devices Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5675007
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Insulin Delivery Devices Market is projected to reach USD 36.45 Billion in 2026. It is expected to continue growing at a CAGR of 8.15%, reaching USD 58.63 Billion by 2032.

The insulin delivery devices market is expanding as diabetes prevalence rises and care models move toward more precise, connected, and patient-centered treatment. WHO reports that more than 830 million people were living with diabetes in 2022, while the International Diabetes Federation estimates 537 million adults aged 20-79 had diabetes in 2021, underscoring sustained demand for insulin pens, insulin pumps, patch pumps, smart caps, infusion sets, and automated insulin delivery systems.

Growth is supported by broader use of continuous glucose monitoring, telehealth, and value-based diabetes management. For manufacturers, payers, and providers, the priority is shifting from device adoption alone to measurable outcomes, including better time-in-range, fewer hypoglycemic events, improved adherence, safer insulin titration, and lower long-term complication risk.

Transformative Shifts in the Insulin Delivery Landscape

The competitive landscape is being reshaped by connected insulin pens, tubeless pumps, interoperable pump-CGM ecosystems, and automated insulin delivery algorithms. Regulatory pathways in the United States and Europe increasingly support interoperable diabetes technologies, enabling patients and clinicians to combine compatible components while encouraging innovation across hardware, software, and data services.

At the same time, affordability, training, reimbursement, cybersecurity, usability, and supply-chain resilience remain decisive market factors. Companies that simplify onboarding, reduce device burden, document clinical value, and support remote care are better positioned as diabetes care moves from episodic clinic visits to continuous digital management.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across insulin delivery devices, especially in automated insulin delivery systems that adjust basal insulin based on glucose trends. AI-enabled analytics can support pattern recognition, dose decision support, predictive alerts, and personalized coaching when integrated with CGM, insulin dosing history, meals, activity, and clinical context.

The opportunity is significant, but adoption depends on clinical validation, transparent performance, privacy protection, and safe human oversight. Industry leaders must treat AI as a regulated clinical capability rather than a marketing feature, with evidence generation focused on time-in-range, hypoglycemia reduction, usability, equity, alarm burden, and real-world adherence.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

North America remains a leading region for advanced insulin delivery devices, supported by high diabetes diagnosis rates, established reimbursement channels, broad CGM adoption, and FDA-cleared interoperable diabetes technologies. Europe benefits from structured health systems, strong clinical guidelines, and growing use of connected pens and pumps, although reimbursement varies by country under national health technology assessment and payer policies.

Asia-Pacific shows the strongest structural opportunity due to large diabetes populations in China, India, Japan, South Korea, and Australia, combined with expanding specialty care, digital health access, and rising awareness of insulin intensification. Latin America is advancing through private-sector adoption and public diabetes programs, with Brazil and Mexico anchoring regional demand. The Middle East faces a high diabetes burden and rising investment in premium care, specialist clinics, and digital health infrastructure. Africa remains underpenetrated, with access, affordability, insulin availability, cold-chain reliability, and clinician training shaping near-term demand.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, expanding urban healthcare infrastructure, pharmacy access, and mobile-first patient engagement are improving the addressable base for insulin pens and connected diabetes tools, although affordability remains critical. GCC countries are investing in diabetes prevention, specialty clinics, and digital health because diabetes prevalence is among the world’s highest in several Gulf states, supporting demand for premium pumps, connected pens, and remote monitoring.

The European Union is shaped by medical device regulation, health technology assessment, data protection requirements, and country-level reimbursement, favoring clinically proven systems with documented patient benefit. BRICS markets combine large patient pools with uneven access, creating demand for scalable, durable, and cost-effective insulin delivery devices. G7 countries lead in premium pump, CGM, connected pen, and AI-enabled adoption due to mature reimbursement and specialist infrastructure, while NATO members overlap substantially with regulated markets where cybersecurity, supply continuity, and device data resilience are strategic priorities.

Key Country Insights Across Major Insulin Delivery Markets

The United States leads in automated insulin delivery innovation, CGM integration, and commercial reimbursement, while Canada shows steady uptake through provincial coverage and specialist-led care. Mexico and Brazil present large opportunities for durable insulin pens and selective pump adoption as private coverage, public diabetes initiatives, and access to endocrinology services evolve.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from strong diabetes care pathways, national clinical guidance, and established reimbursement mechanisms, while Russia faces access, procurement, and regional care variability. China and India represent the largest scale opportunities due to population size, rising diabetes incidence, and expanding hospital and digital health networks. Japan, Australia, and South Korea support high-quality adoption through advanced clinical infrastructure, reimbursement mechanisms, strong patient education, and consumer readiness for connected health technologies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperable device ecosystems, real-world evidence, and affordability strategies. Winning portfolios will combine reliable insulin pens, pumps, patch pumps, consumables, software, and patient support services while proving measurable improvements in adherence, time-in-range, hypoglycemia reduction, and quality of life.

Companies should also strengthen cybersecurity, AI governance, clinician education, human factors design, and payer engagement. Partnerships with CGM developers, telehealth providers, pharmacies, and health systems can accelerate adoption, while localized pricing, training, and service models are essential for emerging markets where access barriers remain high.

Research Methodology

This executive summary is developed using a structured secondary research approach grounded in public health data, regulatory information, clinical evidence, reimbursement trends, and publicly available industry disclosures. Core reference points include WHO, the International Diabetes Federation, CDC, FDA, EMA, national health agencies, peer-reviewed diabetes technology literature, clinical guidelines, and publicly available policy updates.

The analysis triangulates epidemiology, technology adoption, regulatory direction, care delivery trends, reimbursement signals, and regional access factors. Insights are written to support strategic decision-making for insulin delivery device manufacturers, investors, healthcare providers, and digital health partners without relying on unverified claims, unsupported estimates, market sizing, market share, or forecasting.

Conclusion

The insulin delivery devices market is entering a more connected, automated, and evidence-driven phase. Rising diabetes prevalence, broader CGM adoption, and the clinical need for safer insulin management are increasing demand for insulin pens, smart pens, pumps, patch pumps, infusion sets, and automated insulin delivery systems.

Future leadership will depend on balancing innovation with access. Companies that deliver clinically validated, interoperable, secure, user-friendly, and affordable solutions will be best positioned to improve diabetes outcomes across mature and emerging markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Insulin Delivery Devices Market, by Delivery Method
7.1. Introduction
7.2. Insulin Pens
7.3. Insulin Pumps
7.4. Insulin Syringes
7.5. Jet Injectors
8. Insulin Delivery Devices Market, by Insulin Type
8.1. Introduction
8.2. Intermediate-Acting
8.3. Long-Acting
8.4. Pre-Mixed
8.5. Rapid-Acting
9. Insulin Delivery Devices Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Insulin Delivery Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.3. Clinics
10.4. Homecare Settings
10.5. Hospitals
11. Insulin Delivery Devices Market, by Application
11.1. Introduction
11.2. Gestational Diabetes
11.3. Type 1 Diabetes
11.4. Type 2 Diabetes
12. Insulin Delivery Devices Market, by Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Insulin Delivery Devices Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Insulin Delivery Devices Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Insulin Delivery Devices Market, by Country
15.1. United States
15.2. China
15.3. Germany
15.4. United Kingdom
15.5. India
15.6. Japan
15.7. Russia
15.8. Brazil
15.9. Canada
15.10. Italy
15.11. Mexico
15.12. France
15.13. Spain
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Ascensia Diabetes Care Holdings AG
17.3. B. Braun SE
17.4. Biocon
17.5. Debiotech SA
17.6. Eli Lilly and Company
17.7. Embecta Corp.
17.8. Gerresheimer AG
17.9. ICU Medical, Inc.
17.10. Insulet Corporation
17.11. Jiangsu Delfu medical device Co.,Ltd
17.12. Johnson & Johnson Services, Inc.
17.13. MannKind Corporation
17.14. Medtronic PLC
17.15. Nipro Corporation
17.16. Novo Nordisk A/S
17.17. Owen Mumford Ltd.
17.18. Roche Diabetes Care, Inc.
17.19. Sanofi S.A.
17.20. Sequel Med Tech, LLC
17.21. SOOIL Developments Co., Ltd
17.22. Tandem Diabetes Care, Inc.
17.23. Terumo Corporation
17.24. Wockhardt Limited
17.25. Ypsomed AG
List of Figures
FIGURE 1. GLOBAL INSULIN DELIVERY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL INSULIN DELIVERY DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2032 (%)
FIGURE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 11. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL INSULIN DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL INSULIN DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSULIN PENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSULIN PENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSULIN PENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL INSULIN SYRINGES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL INSULIN SYRINGES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL INSULIN SYRINGES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL JET INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL JET INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL JET INJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL INTERMEDIATE-ACTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL INTERMEDIATE-ACTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL INTERMEDIATE-ACTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL LONG-ACTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL LONG-ACTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL LONG-ACTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL PRE-MIXED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PRE-MIXED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PRE-MIXED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL RAPID-ACTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL RAPID-ACTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL RAPID-ACTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 80. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 82. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 83. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 84. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 85. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 86. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 87. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 89. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 90. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 91. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 92. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 93. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 94. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 96. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 97. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 98. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 99. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 100. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 101. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 103. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 104. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 105. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 106. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 107. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 108. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 110. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 111. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 112. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 113. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 114. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 118. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 119. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 120. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 121. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 122. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 123. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 125. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 126. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 127. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 128. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 129. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 132. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 133. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 135. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 137. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 139. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 140. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 141. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 142. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 143. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 144. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 146. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 147. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 148. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 150. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 151. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 153. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 154. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 155. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 157. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 159. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 160. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 161. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 162. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 163. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 164. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 165. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 166. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 167. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 168. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 169. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 170. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 171. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 172. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 173. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 174. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 175. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 176. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 177. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 178. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 179. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 180. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 181. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 182. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 183. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 184. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 185. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 186. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 187. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 188. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 189. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 190. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 192. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 193. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 194. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 195. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 196. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 197. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 198. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 199. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 200. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 201. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 202. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 203. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 204. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 207. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 208. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 209. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 210. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 211. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 212. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 214. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 215. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 216. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 217. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 218. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 219. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 221. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 222. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 223. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 224. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 225. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 226. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 228. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 229. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 230. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 231. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 232. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 233. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 234. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 236. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 237. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 238. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 239. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 240. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 242. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 243. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 244. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 245. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 246. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 247. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 249. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 250. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 251. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 252. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 253. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 254. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 257. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 258. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 259. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 260. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 261. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 263. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 264. GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 265. GLOBAL INSULIN DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • B. Braun SE
  • Biocon
  • Debiotech SA
  • Eli Lilly and Company
  • Embecta Corp.
  • Gerresheimer AG
  • ICU Medical, Inc.
  • Insulet Corporation
  • Jiangsu Delfu medical device Co.,Ltd
  • Johnson & Johnson Services, Inc.
  • MannKind Corporation
  • Medtronic PLC
  • Nipro Corporation
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • Roche Diabetes Care, Inc.
  • Sanofi S.A.
  • Sequel Med Tech, LLC
  • SOOIL Developments Co., Ltd
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Wockhardt Limited
  • Ypsomed AG

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 36.45 Billion
Forecasted Market Value ( USD ) by 2032 $ 58.63 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Smart Insulin Pens & Pumps Market - Global Forecast 2026-2032 - Product Image

Smart Insulin Pens & Pumps Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Smart Insulin Pen Market - Global Forecast 2026-2032 - Product Image

Smart Insulin Pen Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Insulin Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Insulin Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Human Insulin - Global Strategic Business Report - Product Image

Human Insulin - Global Strategic Business Report

  • Report
  • 376 Pages
  • Global
From
Smart Insulin Pens and Pumps - Global Strategic Business Report - Product Image

Smart Insulin Pens and Pumps - Global Strategic Business Report

  • Report
  • 131 Pages
  • Global
From

About the Market

The Insulin Delivery market is a subset of the larger Diabetes Devices market. It includes products and services that help people with diabetes manage their insulin levels. These products range from insulin pumps and pens to continuous glucose monitors and other accessories. Insulin pumps are the most popular type of insulin delivery device, as they allow for more precise and consistent dosing than traditional injections. Continuous glucose monitors provide real-time data on glucose levels, allowing for more accurate insulin dosing. Other accessories, such as infusion sets and reservoirs, are also available to help people with diabetes manage their insulin levels. Some of the major companies in the Insulin Delivery market include Medtronic, Insulet, Tandem Diabetes Care, and Animas. Other companies, such as Roche, Abbott, and Dexcom, also offer products and services in this market. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.